ABBV vs SMCI: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Super Micro Computer, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-06.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
Super Micro Computer, Inc. · Technology
$30.66
+45.0% upside to fair value
Grade B
QuantHub Verdict
SMCI has more upside to fair value
(+45.0%).
SMCI trades at a lower forward P/E
(14.7x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
SMCI |
| Current Price |
$261.07 |
$30.66 |
| Fair Value Estimate |
$264.30 |
$44.46 |
| Upside to Fair Value |
+1.2%
|
+45.0%
|
| Market Cap |
$461.3B |
$18.4B |
| Forward P/E |
128.0x
|
14.7x
|
| EV / EBITDA |
31.0x
|
13.6x
|
| Price / Sales |
7.3x
|
0.6x
|
| Price / FCF |
22.1x
|
-2.7x
|
| Revenue Growth YoY |
+12.4%
|
+122.7%
|
| Gross Margin |
70.7%
|
8.4%
|
| Operating Margin |
27.6%
|
4.5%
|
| Return on Equity |
68.0%
|
18.2%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
—
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
Super Micro Computer, Inc. is a technology company specializing in server and storage systems, with a strong focus on AI infrastructure. The business quality is medium due to its founder-led management with over 30 years of tenure, a widening moat driven by systems engineering and close partnerships with Nvidia, and rapid revenue growth of 122.7% in the most recent quarter. However, the company f…
Accumulation Zones
| Metric |
ABBV |
SMCI |
| Zone Low |
$198.23 |
$33.34 |
| Zone High |
$224.66 |
$37.79 |
| In Buy Zone? |
No
|
Yes
|